Task: Answer the multiple-choice question.
Question: Which compound exhibits a 5.524% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a.) CN(Cc1ccccc1)S(=O)(=O)c1nnc(NC(=O)c2ccc(F)cc2)s1
b.) CCCn1nnnc1SCC(=O)NCc1ccc2c(c1)OCO2
Answer: b. CCCn1nnnc1SCC(=O)NCc1ccc2c(c1)OCO2
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCn1nnnc1SCC(=O)NCc1ccc2c(c1)OCO2
CCCn1nnnc1SCC(=O)NCc1ccc2c(c1)OCO2
N-(1,3-benzodioxol-5-ylmethyl)-2-(1-propyltetrazol-5-yl)sulfanylacetamide